Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Beam Therapeutics Inc stock

Learn how to easily invest in Beam Therapeutics Inc stock.

Beam Therapeutics Inc is a biotechnology business based in the US. Beam Therapeutics Inc shares (BEAM) are listed on the NASDAQ and all prices are listed in US Dollars. Beam Therapeutics Inc employs 507 staff and has a trailing 12-month revenue of around $60.9 million.

How to buy Beam Therapeutics Inc stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BEAM. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Beam Therapeutics Inc stock price (NASDAQ: BEAM)

Use our graph to track the performance of BEAM stocks over time.

Beam Therapeutics Inc shares at a glance

Information last updated 2023-03-31.
Latest market close$30.62
52-week range$27.77 - $73.27
50-day moving average $39.23
200-day moving average $46.72
Wall St. target price$71.62
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-4.10

Buy Beam Therapeutics Inc stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Beam Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Beam Therapeutics Inc price performance over time

Historical closes compared with the close of $30.62 from 2023-03-31

1 week (2023-03-24) 0.76%
1 month (2023-03-01) -20.47%
3 months (2022-12-30) -21.71%
6 months (2022-09-30) -35.73%
1 year (2022-03-29) -50.64%
2 years (2021-04-01) -61.60%
3 years (2020-04-01) 89.95%
5 years (2018-03-28) N/A

Beam Therapeutics Inc financials

Revenue TTM $60.9 million
Gross profit TTM $-250,674,000
Return on assets TTM -15.02%
Return on equity TTM -33.35%
Profit margin 0%
Book value $10.54
Market capitalisation $2.2 billion

TTM: trailing 12 months

Beam Therapeutics Inc share dividends

We're not expecting Beam Therapeutics Inc to pay a dividend over the next 12 months.

Beam Therapeutics Inc share price volatility

Over the last 12 months, Beam Therapeutics Inc's shares have ranged in value from as little as $27.77 up to $73.27. A popular way to gauge a stock's volatility is its "beta".

BEAM.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Beam Therapeutics Inc's is 1.6924. This would suggest that Beam Therapeutics Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Beam Therapeutics Inc overview

Beam Therapeutics Inc. , a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency. The company has research collaboration agreement with Pfizer Inc. , focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc. , for cardiovascular disease treatments; Sana Biotechnology, Inc. , to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease; and the Institute of Molecular and Clinical Ophthalmology Basel for treatment of impaired vision and blindness.

Frequently asked questions

What percentage of Beam Therapeutics Inc is owned by insiders or institutions?
Currently 1.931% of Beam Therapeutics Inc shares are held by insiders and 87.6% by institutions.
How many people work for Beam Therapeutics Inc?
Latest data suggests 507 work at Beam Therapeutics Inc.
When does the fiscal year end for Beam Therapeutics Inc?
Beam Therapeutics Inc's fiscal year ends in December.
Where is Beam Therapeutics Inc based?
Beam Therapeutics Inc's address is: 238 Main Street, Cambridge, MA, United States, 02142
What is Beam Therapeutics Inc's ISIN number?
Beam Therapeutics Inc's international securities identification number is: US07373V1052

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site